These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 11713814

  • 1. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P, Jacob Y, Desmézières E, Tordo N.
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [Abstract] [Full Text] [Related]

  • 2. Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines.
    Desmézières E, Jacob Y, Saron MF, Delpeyroux F, Tordo N, Perrin P.
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2343-2351. PubMed ID: 10501486
    [Abstract] [Full Text] [Related]

  • 3. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    Evans JS, Selden D, Wu G, Wright E, Horton DL, Fooks AR, Banyard AC.
    J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
    [Abstract] [Full Text] [Related]

  • 4. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S, Chaturvedi VK, Rai A, Saini M, Chandra R, Saini Y, Gupta PK.
    Vaccine; 2007 May 16; 25(20):4020-8. PubMed ID: 17391817
    [Abstract] [Full Text] [Related]

  • 5. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M, Saxena A, Rai A, Bhatnagar R.
    FASEB J; 2010 Jan 16; 24(1):173-83. PubMed ID: 19741168
    [Abstract] [Full Text] [Related]

  • 6. Rabies: epidemiological tendencies and control tools.
    Tordo N, Bahloul C, Jacob Y, Jallet C, Perrin P, Badrane H.
    Dev Biol (Basel); 2006 Jan 16; 125():3-13. PubMed ID: 16878455
    [Abstract] [Full Text] [Related]

  • 7. Development of combined vaccines for rabies and immunocontraception.
    Wu X, Franka R, Svoboda P, Pohl J, Rupprecht CE.
    Vaccine; 2009 Nov 27; 27(51):7202-9. PubMed ID: 19925954
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC.
    Virology; 1994 Feb 15; 199(1):132-40. PubMed ID: 8116236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N, Kaushik P, Rai A.
    Acta Virol; 2005 Feb 15; 49(3):207-10. PubMed ID: 16178518
    [Abstract] [Full Text] [Related]

  • 12. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M.
    Acta Virol; 2006 Feb 15; 50(2):87-92. PubMed ID: 16808325
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ, Yang Y, Wilson JM, Ertl HC.
    Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532
    [Abstract] [Full Text] [Related]

  • 16. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S, Bruegger D, Zahno ML, Vogt HR, Peterhans E, Zanoni R, Bertoni G.
    Vaccine; 2008 Dec 09; 26(52):6749-53. PubMed ID: 18955098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL, Esposito JJ, Ewalt LC.
    Vaccine; 2004 Sep 03; 22(25-26):3329-33. PubMed ID: 15308356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.